Turkey · Delayed Price · Currency is TRY IST:ORZAX Statistics
Total Valuation
IST:ORZAX has a market cap or net worth of TRY 29.26 billion. The enterprise value is 33.44 billion.
| Market Cap | 29.26B |
| Enterprise Value | 33.44B |
Important Dates
The next estimated earnings date is Thursday, September 24, 2026.
| Earnings Date | Sep 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IST:ORZAX has 338.50 million shares outstanding. The number of shares has increased by 333.21% in one year.
| Current Share Class | 246.40M |
| Shares Outstanding | 338.50M |
| Shares Change (YoY) | +333.21% |
| Shares Change (QoQ) | -2.94% |
| Owned by Insiders (%) | 31.89% |
| Owned by Institutions (%) | 0.19% |
| Float | 52.50M |
Valuation Ratios
The trailing PE ratio is 22.93.
| PE Ratio | 22.93 |
| Forward PE | n/a |
| PS Ratio | 3.43 |
| PB Ratio | 8.27 |
| P/TBV Ratio | 8.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 28.89 |
| EV / Sales | 3.92 |
| EV / EBITDA | 11.42 |
| EV / EBIT | 12.34 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 1.44.
| Current Ratio | 1.56 |
| Quick Ratio | 0.90 |
| Debt / Equity | 1.44 |
| Debt / EBITDA | 1.74 |
| Debt / FCF | -5.40 |
| Interest Coverage | 1.84 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 27.05% |
| Return on Capital Employed (ROCE) | 58.22% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 8.27M |
| Profits Per Employee | 1.12M |
| Employee Count | 1,032 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IST:ORZAX has paid 450.09 million in taxes.
| Income Tax | 450.09M |
| Effective Tax Rate | 28.00% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 41.69 |
| Average Volume (20 Days) | 6,156,467 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IST:ORZAX had revenue of TRY 8.53 billion and earned 1.16 billion in profits. Earnings per share was 3.77.
| Revenue | 8.53B |
| Gross Profit | 5.63B |
| Operating Income | 2.71B |
| Pretax Income | 1.61B |
| Net Income | 1.16B |
| EBITDA | 2.91B |
| EBIT | 2.71B |
| Earnings Per Share (EPS) | 3.77 |
Balance Sheet
The company has 934.71 million in cash and 5.11 billion in debt, with a net cash position of -4.17 billion or -12.33 per share.
| Cash & Cash Equivalents | 934.71M |
| Total Debt | 5.11B |
| Net Cash | -4.17B |
| Net Cash Per Share | -12.33 |
| Equity (Book Value) | 3.54B |
| Book Value Per Share | 10.46 |
| Working Capital | 3.05B |
Cash Flow
In the last 12 months, operating cash flow was -392.87 million and capital expenditures -552.93 million, giving a free cash flow of -945.80 million.
| Operating Cash Flow | -392.87M |
| Capital Expenditures | -552.93M |
| Depreciation & Amortization | 203.33M |
| Net Borrowing | 3.16B |
| Free Cash Flow | -945.80M |
| FCF Per Share | -2.79 |
Margins
Gross margin is 66.02%, with operating and profit margins of 31.75% and 13.57%.
| Gross Margin | 66.02% |
| Operating Margin | 31.75% |
| Pretax Margin | 18.84% |
| Profit Margin | 13.57% |
| EBITDA Margin | 34.14% |
| EBIT Margin | 31.75% |
| FCF Margin | n/a |
Dividends & Yields
IST:ORZAX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 76.20% |
| Buyback Yield | -333.21% |
| Shareholder Yield | -333.21% |
| Earnings Yield | 3.96% |
| FCF Yield | -3.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IST:ORZAX has an Altman Z-Score of 2.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.39 |
| Piotroski F-Score | 2 |